Vimarsana
Biggest News Aggregation in the World

Page 2 - Ryan Saadi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ryan Saadi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ryan Saadi Today - Breaking & Trending Today

Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments - Vimarsana News

Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments

Conversion of promissory notes into common stock removed $94.9 million in pro forma balance sheet liabilities.The converted common stock is included in the company’s total 165 million outstanding...

Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI ... - Vimarsana News

Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI ...

Conversion of promissory notes into common stock removed $94.9 million in pro forma balance sheet liabilities.The converted common stock is included in the company’s total 165 million outstanding shares.The Tevogen.ai

People moves: Wall Street veteran Tapan Shah joins Tevogen Bio Holdings - Vimarsana News

People moves: Wall Street veteran Tapan Shah joins Tevogen Bio Holdings

A veteran Wall Street professional has taken over as head of investor relations and corporate development at biotechnology comp

Tevogen Bio Appoints Tapan V Shah as Head of Investor - Vimarsana News

Tevogen Bio Appoints Tapan V Shah as Head of Investor

Mr. Shah, a Wall Street veteran with over 25 years of experience, brings broad leadership capabilities to Tevogen Bio....

Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development - Vimarsana News

Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development

WARREN, N.J., April 03, 2024 -- Tevogen Bio Holdings Inc , a clinical-stage biotech company, announces the appointment of Tapan V Shah as Head of Investor Relations and Corporate Development....